In breast cancer cells, an antibody (18A4 mAb) that showed a specific binding to AGR2 in the cytoplasm using immunofluorescent staining was revealed to inhibit the growth of the breast cancer cell line MCF7 [106]. The gene discussed is AGR2; the disease is breast carcinoma.